ETR:BNR Brenntag (BNR) Stock Price, News & Analysis €65.08 -0.22 (-0.34%) (As of 07/25/2024 ET) Add Compare Share Share Today's Range€64.24▼€65.2450-Day Range€62.96▼€69.6652-Week Range€64.52▼€87.12Volume193,097 shsAverage VolumeN/AMarket Capitalization$9.40 billionP/E Ratio15.13Dividend Yield3.23%Price TargetN/A Stock AnalysisStock AnalysisChartHeadlinesStock AnalysisChartHeadlines Get Brenntag alerts: Email Address Ad Unstoppable Prosperity“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. About Brenntag Stock (ETR:BNR)Brenntag SE purchases and supplies various industrial and specialty chemicals, and ingredients in Germany, Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company operates in two segments, Brenntag Essentials and Brenntag Specialties. It provides just-in-time delivery, product mixing, blending, repackaging, inventory management, and drum return handling. The company serves customers in various end-market industries, including nutrition, pharma, personal care, water treatment, and lubricants; and home, industrial, and institutional markets, as well as coatings and constructions, polymers, and rubber industries. The company was founded in 1874 and is based in Essen, Germany.Read More BNR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BNR Stock News HeadlinesMay 16, 2024 | finance.yahoo.comTop German Dividend Stocks To Watch In May 2024May 3, 2024 | afr.comBulletin Resources LimitedJuly 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.April 22, 2024 | finance.yahoo.comThose who invested in Brenntag (ETR:BNR) five years ago are up 76%April 19, 2024 | finance.yahoo.comGlobal Vaccine Adjuvants Market Size To Worth USD 1.51 Billion By 2033 | CAGR of 3.9%March 16, 2024 | wsj.comBrenntag SEMarch 10, 2024 | finance.yahoo.comEarnings Miss: Brenntag SE Missed EPS By 6.0% And Analysts Are Revising Their ForecastsMarch 9, 2024 | finance.yahoo.comBrenntag Full Year 2023 Earnings: Misses ExpectationsJuly 26, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.March 4, 2024 | finance.yahoo.comWith 64% ownership in Brenntag SE (ETR:BNR), institutional investors have a lot riding on the businessJanuary 29, 2024 | seekingalpha.comBrenntag: Why The Company Is Great, But No Longer A 'Buy' (Rating Downgrade)January 14, 2024 | finance.yahoo.comShould You Investigate Brenntag SE (ETR:BNR) At €82.10?January 1, 2024 | sg.finance.yahoo.comRupee's direction guided by Fed outlook, RBI at start of 2024December 16, 2023 | finance.yahoo.comIs There An Opportunity With Brenntag SE's (ETR:BNR) 31% Undervaluation?November 8, 2023 | finance.yahoo.comBrenntag (ETR:BNR) shareholders have earned a 12% CAGR over the last five yearsOctober 4, 2023 | fxstreet.comBond sell off continues to push yields to highs not seen since GFC, weighing on equitiesSeptember 25, 2023 | finance.yahoo.comWith 63% ownership of the shares, Brenntag SE (ETR:BNR) is heavily dominated by institutional ownersAugust 21, 2023 | finance.yahoo.comBrenntag (ETR:BNR) Shareholders Will Want The ROCE Trajectory To ContinueSee More Headlines Receive BNR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Brenntag and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeETR SectorBasic Materials Industry Specialty Chemicals Sub-IndustryN/A Current SymbolETR:BNR CUSIPN/A CIKN/A Webwww.brenntag.com Phone49 201 6496 1141FaxN/AEmployees17,709Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)€4.30 Trailing P/E Ratio15.13 Forward P/E Ratio11.05 P/E Growth0.39Net Income$640.40 million Net Margins3.93% Pretax MarginN/A Return on Equity14.41% Return on Assets5.67% Debt Debt-to-Equity Ratio60.29 Current Ratio1.61 Quick Ratio1.19 Sales & Book Value Annual Sales$16.29 billion Price / Sales0.58 Cash Flow€10.40 per share Price / Cash Flow6.26 Book Value€31.08 per share Price / Book2.09Miscellaneous Outstanding Shares144,380,000Free FloatN/AMarket Cap$9.40 billion OptionableNot Optionable Beta0.94 The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesDr. Christian Kohlpaintner (Age 61)Chairman of the Management Board & CEO Comp: $2.41MDr. Kristin Neumann (Age 52)CFO & Member of the Management Board Comp: $1.2MMr. Ewout Van JarwaardeCEO of Brenntag Essentials & Member of the Management BoardMr. Michael Friede (Age 44)CEO of Brenntag Specialties & Member of the Board of Management Comp: $1.19MMr. Thomas AltmannSenior Vice President of Investor RelationsMs. Marion J. G. Mestrom (Age 63)Chief Human Resources Officer Ms. Ursula Baumgartner-DurchschlagHead of Laboratory & Qualified PersonMore ExecutivesKey CompetitorsSymriseETR:SY1CovestroETR:1COVWacker ChemieETR:WCHFuchsETR:FPE3LANXESS AktiengesellschaftETR:LXSView All Competitors BNR Stock Analysis - Frequently Asked Questions How have BNR shares performed this year? Brenntag's stock was trading at €83.22 on January 1st, 2024. Since then, BNR stock has decreased by 21.8% and is now trading at €65.08. View the best growth stocks for 2024 here. What other stocks do shareholders of Brenntag own? Based on aggregate information from My MarketBeat watchlists, some other companies that Brenntag investors own include Agilent Technologies (A), Alcoa (AA), Advance Auto Parts (AAP), Covestro (1COV), AbbVie (ABBV), Ambev (ABEV). This page (ETR:BNR) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Brenntag SE Please log in to your account or sign up in order to add this asset to your watchlist. Share Brenntag With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.